Ranolazine Mediated PVC Reduction in Ischemic Heart Disease
Status:
Completed
Trial end date:
2018-02-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether ranolazine has beneficial effects on
cardiac ischemia through reduction of premature ventricular contraction burden.